News
The path to a better tuberculosis vaccine runs through Missoula, Montana based Inimmune
April 19, 2024 /
MATR Sponsor (view all)
A team of University of Montana researchers is playing a key role in the development of a more effective vaccine against an infectious disease that has killed more people than any other.
Jay Evans, the director of the University of Montana center and the chief scientific and strategy officer and a co-founder of Inimmune, a privately held biotechnology company in Missoula, said his team has been working on a TB vaccine for 15 years. The private-public partnership is developing vaccines and trying to improve existing vaccines, and he said it’s still five years off before the TB vaccine might be distributed widely.
MATR Supporters (view all)
Posted in: Biotech, 21st Century Education Initiative - "You Should Care...", Education News, Montana Education/Business Partnerships, University of Montana & Montana State University Tech Transfer, Montana Education Excellence, Montana Leadership, Community, VR/AR, Blockchain, Bitcoin, Artificial Intelligence and The Internet of Things
Sorry, we couldn't find any posts. Please try a different search.